Q32 Bio Inc.
QTTB
$1.55
-$0.135-8.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.36% | -3.63% | -1,749.95% | 103.80% | -92.91% |
| Total Depreciation and Amortization | -2.44% | 1.65% | -1.63% | -0.81% | 0.00% |
| Total Amortization of Deferred Charges | -2.00% | -24.24% | 127.59% | -3.33% | 328.57% |
| Total Other Non-Cash Items | 37.23% | -11.55% | 108.80% | -914.40% | -72.18% |
| Change in Net Operating Assets | 129.70% | 51.47% | -1,072.92% | -104.02% | -37.96% |
| Cash from Operations | 41.46% | 12.12% | -52.66% | -35.80% | -167.39% |
| Capital Expenditure | 96.55% | -286.67% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 0.98% | 10,109.28% | -- | -- |
| Cash from Investing | -100.02% | 0.55% | 10,093.81% | -- | 100.00% |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | -- | 100.00% | -109.89% | -- | 100.00% |
| Issuance of Common Stock | -68.20% | 162.37% | -99.10% | 55,163.16% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -68.20% | 118.06% | -105.56% | 130,618.42% | -74.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.48% | 51.91% | -121.02% | 897.93% | -165.67% |